evaluate the pharmaceuticals company saxenda on glp-1 medications best medication Wegovy® and Saxenda® are both GLP-1 designed to support weight care – but they're not the same. 👀 Weekly vs. daily injections evaluate the pharmaceuticals company saxenda
Description
Given that research shows weight regain is common after stopping semaglutide , having a clear maintenance pathway is essential
The small molecule was discovered using EraCals platform technology and uses a new mechanism of action to regulate appetite and body weight
95% CI 0.03 to 0.06
In 2024, semaglutide 2.4 mg (Wegovy) received FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity, based on the SELECT trial
2018;20 Suppl 1:5-21
